Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study

M. N. Ghazanfar, J. G. Holm, S. F. Thomsen

14 Citations (Scopus)

Original language	English
Book series	Journal of the European Academy of Dermatology and Venereology. Supplement
Volume	32
Issue number	10
Pages (from-to)	1761-1767
ISSN	0926-9959
DOIs	https://doi.org/10.1111/jdv.15045
Publication status	Published - Oct 2018

Access to Document

Research output: Contribution to journal › Journal article › Research › peer-review

@article{d5870814279b49ca97e03bb6e47ae936,

title = "Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study",

author = "Ghazanfar, {M. N.} and Holm, {J. G.} and Thomsen, {S. F.}",

year = "2018",

month = oct,

doi = "10.1111/jdv.15045",

language = "English",

volume = "32",

pages = "1761--1767",

journal = "Journal of the European Academy of Dermatology and Venereology. Supplement",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes

T2 - a prospective study

AU - Ghazanfar, M. N.

AU - Holm, J. G.

AU - Thomsen, S. F.

PY - 2018/10

Y1 - 2018/10

U2 - 10.1111/jdv.15045

DO - 10.1111/jdv.15045

M3 - Journal article

C2 - 29729103

SN - 0926-9959

VL - 32

SP - 1761

EP - 1767

JO - Journal of the European Academy of Dermatology and Venereology. Supplement

JF - Journal of the European Academy of Dermatology and Venereology. Supplement

IS - 10

ER -